| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 03/11/2010 | US20100063038 Substituted 4-Amino-Pyrrolotriazine Derivatives Useful for Treating Hyper-Proliferative Disorders and Diseases Associated with Angiogenesis |
| 03/11/2010 | US20100062995 Transition state structure of human 5'methylthioadenosine phosphorylase |
| 03/11/2010 | US20100062982 Avian derived fusion proteins |
| 03/11/2010 | US20100062977 TCR-Independent Activation of T Cells |
| 03/11/2010 | US20100062542 Antibody against aflatoxins, support using the antibody, method of immunologically detecting aflatoxins and method of concentrating and purifying aflatoxins |
| 03/11/2010 | US20100062534 Inducible lentiviral vectors for reprogramming somatic cells |
| 03/11/2010 | US20100062533 Nuclear reprogramming factor and induced pluripotent stem cells |
| 03/11/2010 | US20100062531 RGD Containing Recombinant Gelatin |
| 03/11/2010 | US20100062530 Cell culture method, cell culture system and culture medium adjustement apparatus |
| 03/11/2010 | US20100062529 Apparatus and method for the deposition of biological material in a target substrate |
| 03/11/2010 | US20100062528 Method for packaging cells in culture in a low-pressure environment, and corresponding device |
| 03/11/2010 | US20100062527 Induction, propagation and isolation of liver progenitor cells |
| 03/11/2010 | US20100062526 Optimized messenger rna |
| 03/11/2010 | US20100062525 Optically responsive and mechanically tunable colloid-in-liquid crystal gels |
| 03/11/2010 | US20100062524 Methods and compositions relating to improved lentiviral vector production systems |
| 03/11/2010 | US20100062489 Duck embryonic derived stem cell lines for the production of viral vaccines |
| 03/11/2010 | US20100062487 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses |
| 03/11/2010 | US20100062479 Method and device |
| 03/11/2010 | US20100062477 Methods of isolating and propagating stem cells from benign tumors |
| 03/11/2010 | US20100062462 Immunodeficiency viruses |
| 03/11/2010 | US20100062456 Using g protein coupled receptor to identify modulators of taste signal transduction; generating of taste topographic maps that elucidate relationship between taste cells of tongue and taste sensory neurons in brain |
| 03/11/2010 | US20100062449 Method Of Measuring PTX3 With High Sensitivity |
| 03/11/2010 | US20100062435 Methods for Stem Cell Production and Therapy |
| 03/11/2010 | US20100062417 Zeolite crystals with biological material |
| 03/11/2010 | US20100062137 Modulating plant tocopherol levels |
| 03/11/2010 | US20100062048 Topical co-enzyme q10 formulations and treatment of pain, fatigue and wounds |
| 03/11/2010 | US20100062041 Skin sunstitutes, preparation methods and uses thereof |
| 03/11/2010 | US20100062038 Markers, Antibodies and Recombinant scFvs for Mesenchymal Stem Cell Sub-populations and Osteoclasts |
| 03/11/2010 | US20100062036 Multiblock Copolymers with Shape-Memory Properties |
| 03/11/2010 | US20100062015 Fusion protein vaccine |
| 03/11/2010 | US20100062013 Cancer antigen peptides derived from wt1 |
| 03/11/2010 | US20100062010 Novel peptide compound |
| 03/11/2010 | US20100062002 Brain Endothelial Cell Expression Patterns |
| 03/11/2010 | US20100062000 Rhamm, a Co-Receptor and Its Interactions with Other Receptors in Cancer Cell Motility and the Identification of Cancer Prognitor Cell Populations |
| 03/11/2010 | US20100061997 Transgenic Non-Human Animals Expressing A Truncated Activin Type II Receptor |
| 03/11/2010 | US20100061996 Methods and compositions for modulating hepsin activation of urokinase-type plasminogen activator |
| 03/11/2010 | US20100061985 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders |
| 03/11/2010 | US20100061977 Methods and compositions for treating and diagnosing diseases |
| 03/11/2010 | US20100061974 Transcobalamin receptor polypeptides, nucleic acids, and modulators thereof, and related methods of use in modulating cell growth and treating cancer and cobalamin deficiency |
| 03/11/2010 | US20100061973 Graded Expression of Snail as Marker of Cancer Development and DNA Damage-Based Diseases |
| 03/11/2010 | US20100061966 Cardiac Stem Cells |
| 03/11/2010 | US20100061965 Respiratory syncytial virus renders dendritic cells tolerogenic |
| 03/11/2010 | US20100061964 Method for preparing pancreatic beta cells starting from beta cell progenitors and beta cells thereby obtained |
| 03/11/2010 | US20100061963 Methods of Improving Stem Cell Homing and Engraftment |
| 03/11/2010 | US20100061961 Recombinant super-compound interferon |
| 03/11/2010 | US20100061937 Delivery of contrasting agents for magnetic resonance imaging |
| 03/11/2010 | CA2738034A1 Materials and methods for inhibiting cancer cell invasion related to fgfr4 |
| 03/11/2010 | CA2736314A1 Periostin-induced pancreatic regeneration |
| 03/11/2010 | CA2736178A1 Methods for the detection of circulating tumor cells |
| 03/11/2010 | CA2735800A1 Expansion of haemopoietic precursors |
| 03/11/2010 | CA2735790A1 Adherent cells from placenta tissue and use thereof in therapy |
| 03/11/2010 | CA2734704A1 Monoclonal antibody and immunoassay using the same |
| 03/10/2010 | EP2161340A2 Optimized T-DNA transfer and vectors therefor |
| 03/10/2010 | EP2161338A1 Isolated mammalian monocyte cell genes; related reagents |
| 03/10/2010 | EP2161336A1 Human monoclonal antibodies to programmed death 1(PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics |
| 03/10/2010 | EP2161330A1 Experimental models of age-related macular degeneration and related retinal disorders |
| 03/10/2010 | EP2161286A1 Antibodies |
| 03/10/2010 | EP2161280A2 Genes involved in the regulation of angiogenesis, pharmaceutical preparations containing them and their applications |
| 03/10/2010 | EP2160470A2 Chimeric pufa polyketide synthase systems and uses thereof |
| 03/10/2010 | EP2160411A1 Anti-vpac1 antibodies and their uses |
| 03/10/2010 | EP2160403A1 Methods of producing a secreted protein |
| 03/10/2010 | EP2160100A2 Treatment of graft-versus-host disease |
| 03/10/2010 | EP2021484B1 Expression vectors comprising the hs1 promoter of the vav1 oncogene and use thereof for the preparation of pharmaceutical compositions intended for somatic gene therapy |
| 03/10/2010 | EP1765498B1 Bioreactor for studying the effects of imposed stimuli on cellular activity |
| 03/10/2010 | EP1677833B1 Virus vector for use in in vivo gene therapy of Parkinson's disease |
| 03/10/2010 | EP1641474B1 Therapeutical composition containing dentritic cells and use thereof |
| 03/10/2010 | EP1544293B1 Antibody against enzyme specifically cleaving von villebrand factor and assay system using the same |
| 03/10/2010 | EP1521835B1 Use of ahas mutant genes as selection marker in potato transformation |
| 03/10/2010 | EP1483588B1 Screening method for identifying protective substances for treating neurodegenerative and/or ischemic disorders |
| 03/10/2010 | EP1446484B1 Nucleotide sequence coding for a modified protein of interest, expression vector and method for obtaining same |
| 03/10/2010 | EP1274833B1 A method to prevent graft rejection using tgf-beta to induce t suppressor cells |
| 03/10/2010 | EP0932678B2 A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 03/10/2010 | CN101668849A Cancer disease modifying antibody 010207-01 produced by hybridoma cell line ar51a630.3 |
| 03/10/2010 | CN101668846A Non-simian cells for growth of porcine reproductive and respiratory syndrome (prrs) virus |
| 03/10/2010 | CN101668845A Methods of protein production using anti-senescence compounds |
| 03/10/2010 | CN101665794A Nucleic acid molecules encoding alternansucrase |
| 03/10/2010 | CN101665782A Cell line used for susceptibility detection of lung cancer chemotherapy drugs and establishment thereof |
| 03/10/2010 | CN101665536A Anti-vegf antibodies |
| 03/10/2010 | CN100593570C Enzymes mixture |
| 03/10/2010 | CN100593544C Mutants of the P4 protein of nontypable haemophilus influenzae with reduced enzymatic activity |
| 03/09/2010 | US7674960 Garden bean line EX 15340804 |
| 03/09/2010 | US7674957 Stress responsive transcription factor involved in plant growth and development and methods thereof |
| 03/09/2010 | US7674956 Hydrolases; insect/disease resistant plants; controlling cellulose concentration during cell wall deposition |
| 03/09/2010 | US7674955 transgenic plant stably transformed with a gene encoding a Hd-Zip domain; drought resistant; |
| 03/09/2010 | US7674894 Nucleic acid molecule having promoter activity; expressing herbicide tolerance gene in plants |
| 03/09/2010 | US7674893 Promoters for regulation of gene expression in plant roots |
| 03/09/2010 | US7674891 encoding CD36, Gqi9, and G protein-coupled receptor 84 (GPR84) proteins; permits the screening for modulators of taste activity |
| 03/09/2010 | US7674621 Lambda phages useful in introducing recombineering functions into host cells; origin of replication (ori) selected from pSC101, colE1, pBBR1 and RK2 |
| 03/09/2010 | US7674620 Derivation of terminally differentiated dopaminergic neurons from human embryonic stem cells |
| 03/09/2010 | US7674618 Expression vector |
| 03/09/2010 | US7674611 An isolated protein comprising the amino acid sequence of SEQ ID NO: 1, and having an ethylenediamine-N,N'-disuccinate:ethylenediaminelyase activity and having improved heat resistance |
| 03/09/2010 | US7674607 DNA encoding G+C-rich promoter binding protein |
| 03/09/2010 | US7674596 Transfected cell line and a method using the same for the high throughput screening for inhibitors of the T-type calcium channel alpha-1H |
| 03/09/2010 | US7674586 Methods of identifying modulators of L-glutamate-gated chloride channel proteins from Rhipicephalus sanguineus |
| 03/09/2010 | US7674470 Comprises clostridial neurotoxin light chain domains; endopeptidases; vaccines; fusion proteins; for inhibiting exocytosis |
| 03/09/2010 | US7674463 Method of inhibiting angiogenesis by administration of a corticotropin releasing factor receptor 2 agonist |
| 03/09/2010 | US7674462 Transforming growth factor receptor specific immunoglobulin for use in diagnosis prvention and treatment of tumor disorders; immunotherapy |
| 03/09/2010 | US7674457 treating neurodegenerative disorders by administering a human umbilical cord blood and mannitol blood brain barrier permeabilizer; biodrug treating cerebral ischemia; cells are selected from all different organs |
| 03/09/2010 | US7674456 Breast cancer cell lines and uses thereof |
| 03/09/2010 | US7674455 treating a mammal having amyotrophic lateral sclerosis by transducing a motor neuron of the mammal with an insulin-like growth factor I (IGF-1) gene or a glial cell line-derived neurotrophic factor (GDNF) gene; neurodegenerative disorders |